on VINPAI (isin : FR001400AXT1)
Camlin Fine Sciences Adjusts Vinpai Takeover Plans
Camlin Fine Sciences Limited (CFSL) has announced a delay in filing its simplified cash tender offer for Vinpai shares. Originally planned for February 2026, the filing is now postponed till early May 2026. The delay allows Vinpai's 2025 financial results to be included in the offer documentation.
CFSL aims to keep Vinpai listed on Euronext Growth Paris, opting against a squeeze-out, as part of a broader European restructuring strategy. Maintaining the listing will help Vinpai access financial markets for debt restructuring and future project financing.
Vinpai is recognized for its functional ingredients, impacting the food and cosmetics sectors. Camlin holds 78.68% of Vinpai's share capital, following a majority acquisition completed in November 2025. The tender offer price remains €3.60 per share.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VINPAI news